Arbutus Biopharma (ABUS) Capital Expenditures Growth (5y) (2018 - 2024)
Arbutus Biopharma (ABUS) Capital Expenditures Growth (5y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 6.42% |
| Jun 30, 2024 | -66.58% |
| Mar 31, 2024 | 25.10% |
| Sep 30, 2023 | -33.00% |
| Jun 30, 2023 | 15.11% |
| Mar 31, 2023 | -13.95% |
| Dec 31, 2022 | -6.55% |
| Sep 30, 2022 | -29.91% |
| Jun 30, 2022 | -41.60% |
| Mar 31, 2022 | -53.43% |
| Dec 31, 2021 | -53.26% |
| Sep 30, 2021 | -40.40% |
| Jun 30, 2021 | -7.91% |
| Mar 31, 2021 | -18.54% |
| Dec 31, 2020 | -33.56% |
| Sep 30, 2020 | -54.89% |
| Jun 30, 2020 | -29.65% |
| Dec 31, 2019 | -27.88% |
| Sep 30, 2019 | 10.90% |
| Jun 30, 2019 | -0.49% |